BioMicro Systems Awarded US Patent for Invention of a Method and System for Microfluidic Interfacing to Microarrays
News Jun 28, 2007
BioMicro® Systems has announced that it has been awarded US Patent 7,223,363, which the company refers to as the “MAUI® Hybridization System Patent.”
The MAUI Hybridization System Patent was awarded to BioMicro Systems for its invention of a microfluidic interface with microarrays. The MAUI System enables researchers the ability to achieve a 3-10 fold increase in sensitivity and consistent/reproducible results compared to traditional coverslip or static microarray hybridization methods.
BioMicro Systems applied for the MAUI System Patent on March 8, 2002 and it was awarded May 29, 2007.
“I am excited that the BioMicro team has been awarded this breakthrough MAUI System patent for achieving superior microarray hybridization results,” stated Michael Feldman, Ph.D., Chief Executive Officer of BioMicro Systems. “This patent award recognizes the BioMicro research and development team’s innovative expertise in microfluidics and microarray processing, which ultimately benefits the MAUI System customers.”
BioMicro Systems key products include:
• MAUI Hybridization System is a microarray hybridization solution designed for gene expression studies
• MAUI Mixers is a product line of microarray hybridization chambers that address researchers’ high-throughput needs.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.